Renin-angiotensin-aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels
详细信息 查看全文
- 作者：I. Mikolasevica ; b ; 1 ; ivana.mikolasevic@gmail.com" class="auth_mail" title="E-mail the corresponding author ; L. Zaputovicc ; L. Zibard ; I. Begicd ; M. Zutelijae ; A. Klanace ; I. Majurece ; T. Simundicd ; M. Minazekd ; L. Orlica
- 关键词：Angiotensin-converting enzyme inhibitors ; Angiotensin II receptor type 1 blockers ; Kidney transplantation
- 刊名：European Journal of Internal Medicine
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：29
- 期：Complete
- 页码：98-103
- 全文大小：220 K
文摘
- •
RAAS inhibitors are effective in lowering Hb and Htc in recipients with high or high/normal levels.
- •
The use of these drugs has a beneficial impact on erythropoiesis and kidney graft function.
- •
Clinicians should not be worried about their use in RTRs.
- •
The exact mechanism for these observations still has to be investigated.